In addition, patients with high RSK2 and CREB expression had shorter postoperative survival times and worse prognoses, suggesting that RSK2 and CREB may be used as adjuncts to determine the prognosis of HBV-HCC patients. Here, CREB1 is linked to hepatocellular carcinoma.